Finance

It appears most ETF investors aren’t cashing out of technology despite this year’s painful losses.

The widely-held ARK Innovation ETF and the Technology Select Sector SPDR Fund, down 59% and 25% respectively this year, aren’t showing meaningful outflows so far this year.

Invesco’s Anna Paglia lists a reason: Investors are more loyal to the idea of growth than to the market’s near-term swings.

“You do not assess the growth of companies based on what’s happening today, [and] what’s going to happen next month,” the firm’s global head of ETFs and indexed strategies told CNBC’s “ETF Edge” last week. “You assess growth based on what you think is going to happen in five years or 10 years.”

The Nasdaq rallied almost 3% on Friday — climbing more than 2% for the week during a heavy part of earnings season. The tech-heavy index staged a comeback despite Amazon‘s rough performance following Thursday’s quarterly earnings and guidance.

The Nasdaq is still almost 32% from its record high hit last November.

Yet many big volume ETFs including the Proshares Ultrapro QQQ, which tracks the Nasdaq 100, are also holding on to investors. It’s down 74% so far this year.

VettaFi’s Dave Nadig believes future growth prospectics are keeping investors interested. The short and leveraged QQQs in the ETF space have been “stalwarts for volume” ever since launching, according to Nadig.

“We can turn to the QQQ as a perfect example here. The people who are trading short Qs and leverage Qs are not doing that because they’re looking for a more efficient beta for their retirement plan. They’re doing that because they’re making a call in tech,” the firm’s financial futurist said.

Disclaimer

Articles You May Like

Cannabis stocks surge as Biden administration moves to reclassify marijuana
‘Trader justice’: Ex-SocGen trader fired for risky bets claims he was made a ‘scapegoat’
As home sellers, buyers wait on a Fed cut, here’s how mortgage rates have impacted the spring housing market
Johnson & Johnson to pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
Top Wall Street analysts suggest these dividend stocks for income investors